Company

An accomplished senior executive with deep experience in the eye care space, Pierre Bertrand brings more than 20 years of strategic expertise to Neurolens^®. His leadership has helped bolster the national expansion, making the breakthrough Neurolens^® Measurement Device more accessible to private practice optometry nationwide. Prior to joining Neurolens^®, Bertrand served as President of Vision Associates—a division of Essilor Luxottica—where he oversaw more than 200 retail locations across the US. During his eight-year tenure at Essilor Luxottica, Bertrand held executive leadership positions as VP, Marketing for Essilor of America and President, Essilor Canada. Prior to Essilor, Bertrand also held senior leadership positions at Pfizer.

Danny Perales has well over 15 years of experience working with venture backed healthcare companies. In his role as Chief Financial Officer, Perales is responsible for the overall financial and operational needs of the company’s growth strategy. Since joining Neurolens^® in 2014, Perales has also played pivotal roles in the commercial and clinical efforts of the company. Before he joined Neurolens^®, Perales was Director of Finance & Implementation Services at Awarepoint Corp., a healthcare RTLS company, and he also worked in the audit and assurance practice at RSM US.

Aric Plumley is a licensed Professional Engineer in the state of California. As a serial entrepreneur, Mr. Plumley pursued and received his MBA from the University of California, Irvine with an emphasis in Strategy and Marketing. In his career, Plumley has worked across a variety of industries including Semiconductor Manufacturing, Consumer Products, Military defense systems, and for the past 15 years has developed equipment for the eye care industry. Plumley is credited as inventor for several patents in eye care relating to cataract surgical systems as well as binocular measurement systems and treatments. Some of the products he has helped develop are the B&L Stellaris microsurgical system and the Alcon ORA intraoperative wavefront aberrometer. As the Chief Technology Officer for Neurolens, Plumley applies his passion for data science, machine learning and artificial intelligence towards improving patient outcomes.

Stéphane Arcand brings over 20 years of experience in the medical devices field, 11 of which were in ophthalmology. He most recently served as Country Manager at Abbott Structural Heart Canada, leading the overall direction of the affiliate while managing a P&L of $35,000,000. He consistently delivered double-digit sales growth while also leading the planning and implementation strategies for numerous new product launches. As Vice President of Neurolens^® Canada Arcand oversees all facets of market development across the country, including commercial operations.

Gregory Boisse has over 17 years of experience in the optical industry. He spent over 12 years at Essilor Luxottica, where he held a number of key roles in finance and commercial operations. Before joining Neurolens^®, Boisse was the Vice President of Operations at DAC Technologies. At Neurolens^®, Boisse oversees sales operations and analytics, as well as key production teams such as supply chain and quality control.

Kaelin Currie started her career as a public accountant and spent seven years specializing in accounting and property management at a large Real Estate Investment Trust. Her financial background led to the opportunity to join the Neurolens^® team in 2017 as the Director of Finance. Currie has led a number of critical projects in her time at Neurolens^®, and currently leads efforts to continually expand production capabilities through strategic partnerships with wholesale labs and integrated partners.

Nate Schomas brings almost 20 years of Systems Integration and Management Consulting experience to Neurolens^®, as well as several years of experience doing so in the eye care industry, specifically. With a history of success bridging the gap between business strategies and suitable technical solutions, Schomas is responsible for the organization's Software Development and related functions and teams.

Jenny Smith is a seasoned optical speaker and trainer, with almost 15 years of experience in the industry. She joined Neurolens^® in early 2021 to lead efforts to expand Commercial Operations in the eastern United States. Prior to that, Smith spent nine years in the Essilor Luxottica organization, starting her career there successfully supporting a number of major product launches and key initiatives. She became a sought-after speaker for regional and national events and was eventually tapped to lead the Strategic Accounts organization. She is ABOC and a certified speaker to deliver CE and COPE practice management courses. At Neurolens^®, Smith oversees all internal and external training and development initiatives.

Brant Southwell is a seasoned marketing professional with over 15 years of experience in the optical industry, specifically. Southwell previously spent nine years at Essilor Luxottica, leading a number of key marketing initiatives ranging from major product launches to national growth initiatives, and spent several years overseeing the Managed Vision Care and pricing strategies for key product launches. At Neurolens^®, Southwell oversees development and execution of the commercial marketing strategy, including pipeline activation, customer acceleration, product innovation planning, programs, pricing strategy and direct-to-consumer efforts.

Davis Corley co-founded Neurolenses in 2012 leading the company from early stage development to full commercialization. Under his leadership the company is creating a new category of spectacle lenses that not only provide excellent vision but also provide symptom relief for patients who suffer from excessive near work. He began his career at McGladrey, LLP, a CPA firm with the intent of gaining a wide array of business processes and financial discipline. During his time at McGladrey he completed his CPA with distinction as a senior associate of McGladrey. In 2010 he joined a group of Silicon Valley and San Diego based serial entrepreneurs where he focused on company incubation, fund raising, and operations. Davis formerly held the CPA designation, holds a master’s degree in Financial Management and Accounting from the University of San Diego as well as his bachelor’s in accounting. Davis Corley formerly served as CEO of Neurolens, Inc.

Andy Corley served as the President of the Bausch and Lomb Surgical Division from 2008 until 2011 when he formed Yelroc Consulting ( Yelroc is Corley backwards) Yelroc Consulting Inc. focuses on all aspects of company building with an emphasis on high performance management process. Andy is currently Chairman of the Board of RX Sight, Equinox, and eyeBrain Medical. In 2017 he Co-Founded Flying-L Partners with Bill Link and Richard Lindstrom, MD.

Steve Kirby is a founding partner of Bluestem Capital Company. He is a graduate of Arizona State University with a BS Degree in Political Science and a graduate of the University Of South Dakota School Of Law with a Juris Doctorate Degree. Mr. Kirby was secretary and senior claims counsel for Western Surety Company, a national surety bond company, from 1977-1992. He was the 35th Lieutenant Governor of the State of South Dakota from 1993 through 1995. He was also a candidate for Governor of South Dakota in 2001-2002. Mr. Kirby is a member of local, state and national Boards of Directors. He is a speaker at various entrepreneurial and college forums. Steve was recognized with the Spirit of Enterprise Award from South Dakota’s Enterprise Institute for his commitment, dedication and achievements in entrepreneurship. He has received the Spirit of Sioux Falls award in recognition of his leadership and economic development. He also received the USD Financial Management Association’s Outstanding Financial Executive award. Steve is married to Suzette (Hustead) and their children are: a son Jon (employed at Bluestem) and his wife Tracy and family; a daughter Kelly and her husband Travis Behrens and family; and daughter Katherine, all living in Sioux Falls.

Thomas Frinzi is Worldwide President, Surgical, Johnson & Johnson Vision business, which includes a broad ophthalmology portfolio across the areas of cataracts, refractive surgery (LASIK) and dry eye. Tom was appointed to his position in February 2017 at the conclusion of Johnson & Johnson’s acquisition of Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott. Mr. Frinzi joined AMO in January 2016 as Senior Vice President of Abbott Laboratories and President, Abbott Medical Optics. Prior to joining Abbott, Mr. Frinzi held a number of leadership positions in ophthalmology and medical device companies. Most recently, he served as President and CEO of WaveTec Vision, a developer of surgical systems for eye surgery. He also held senior positions in commercial operations, business development, and sales and marketing at Bausch & Lomb Surgical, Refractec and Johnson & Johnson. In recognition of his leadership, expertise and vision in the field, Mr. Frinzi was awarded the 2015 Ophthalmology Innovation Award by the Ophthalmology Innovation Summit. He earned a bachelor’s degree in political science from the University of Tampa.

Das Narayandas is the Edsel Bryant Ford Professor of Business Administration at the Harvard Business School. He is currently the Senior Associate Dean, Harvard Business Publishing. His academic credentials include a Bachelor of Technology degree in Engineering from the Indian Institute of Technology, Bombay (IITB), a Post-Graduate Diploma in Management from the Indian Institute of Management, Bangalore (IIMB), and a Ph.D. in Management from Purdue University.1996 — 2012.POWER VISION Ltd.​ 2011 – 2014.PRACTICE MANAGEMENT SYSTEMS, Ltd.​ 2005 — 2010.LENS MASTER, RUSSIA ​1997 — 2012.1800CONTACTS, Inc.​ 1997 — 2007.VISION EXPRESS GROUP​ 1988 — 1997. LENS CRAFTERS ​1983 — 1987.

William J. Link, Ph.D., specializes in early-stage investing in medical devices. He is a founder and Principal of Flying L Partners and he is a Founder and Managing Director of Versant Ventures. Prior to co-founding Versant Ventures, Dr. Link was a general partner at Brentwood Venture Capital, and has over two decades of operations experience in the healthcare industry. Dr. Link was previously founder, chairman, and CEO of Chiron Vision, which was sold to Bausch and Lomb in 1997. Prior to Chiron Vision, Dr. Link founded and served as President of American Medical Optics (AMO), a division of American Hospital Supply Corporation, which was sold to Allergan in 1986. Later, he served on the Board of AMO’s successor company, Advanced Medical Optics (AMO) which was acquired by Abbott in 2009. AMO was acquired by Johnson and Johnson in 2016. Before entering the healthcare industry, he was an Assistant Professor in the Department of Surgery at the Indiana University School of Medicine. Dr. Link currently serves on the board of several private companies and three public companies, Edwards Lifesciences, Glaukos, and Second Sight Medical Products. He received his B.S., M.S., and Ph.D. from Purdue University, all in Mechanical Engineering.

Eric is a Partner at MVM, a growth equity firm that invests in innovative healthcare companies. Prior to MVM, Eric was a Partner at Advent Healthcare Ventures and a Principal at Advent International Corporation. Before Advent, Eric was a Director in the Corporate Finance Group of Silicon Valley Bank. Eric has a B.S. degree in Neural Science from Brown University and a Ph.D. in Biological Sciences from the University of California, Irvine. In addition to Neurolens, Eric is a member of the board of MDxHealth SA (NASDAQ: MDXH), OptiNose, Inc. (NASDAQ: OPTN), and Vero Biotech, Inc. He was previously a director of AccuVein, Inc., Ambio, Inc., Biotheranostics, Inc. (acquired by Hologic) and Heptares Ltd (acquired by Sosei Group Corporation).

Akhilesh is a Partner at MVM, a growth equity firm that invests in innovative healthcare companies. Prior to MVM, he practiced medicine as a resident at Beth Israel Deaconess Medical Center and Signature Healthcare Brockton Hospital. His research on healthcare systems has led to more than a dozen scientific publications and 50 articles in the popular press, including in The Washington Post and Scientific American. Akhilesh received an MD at the Stanford School of Medicine and an MBA at the Stanford Graduate School of Business. He also holds an AB magna cum laude with highest honors from Harvard University. In addition to Neurolens, Akhilesh is a member of the board of AccuVein, Inc, and was previously a board observer of Patient Connect Ltd (acquired by Clarivate).